Janux Therapeutics Inc (JANX)
49.96
-2.04
(-3.91%)
USD |
NASDAQ |
May 10, 13:58
Janux Therapeutics Price: 49.96 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 09, 2024 | 54.00 | 54.91 | 50.79 | 52.00 | 1.465M |
May 08, 2024 | 53.68 | 58.00 | 51.63 | 55.37 | 1.551M |
May 07, 2024 | 62.67 | 63.37 | 60.39 | 61.50 | 518330.0 |
May 06, 2024 | 63.16 | 63.34 | 57.11 | 62.19 | 869256.0 |
May 03, 2024 | 63.98 | 65.60 | 59.31 | 64.78 | 1.050M |
May 02, 2024 | 59.94 | 64.79 | 56.41 | 62.43 | 1.118M |
May 01, 2024 | 57.00 | 60.05 | 55.53 | 58.19 | 906620.0 |
Apr 30, 2024 | 54.88 | 57.11 | 53.60 | 57.00 | 653594.0 |
Apr 29, 2024 | 47.85 | 61.00 | 47.58 | 56.08 | 1.538M |
Apr 26, 2024 | 47.08 | 48.23 | 46.51 | 47.39 | 573989.0 |
Apr 25, 2024 | 48.30 | 48.30 | 45.68 | 47.10 | 555331.0 |
Apr 24, 2024 | 49.95 | 50.06 | 46.52 | 48.21 | 580167.0 |
Apr 23, 2024 | 49.31 | 50.42 | 48.28 | 49.78 | 706616.0 |
Apr 22, 2024 | 49.66 | 49.95 | 44.71 | 48.88 | 1.119M |
Apr 19, 2024 | 48.14 | 49.13 | 46.45 | 48.69 | 669574.0 |
Apr 18, 2024 | 47.87 | 49.00 | 47.32 | 48.85 | 396836.0 |
Apr 17, 2024 | 50.00 | 51.40 | 47.28 | 47.96 | 614427.0 |
Apr 16, 2024 | 52.10 | 52.33 | 50.02 | 50.55 | 536776.0 |
Apr 15, 2024 | 51.05 | 54.59 | 50.43 | 51.86 | 1.041M |
Apr 12, 2024 | 49.94 | 54.76 | 49.53 | 52.65 | 1.527M |
Apr 11, 2024 | 47.06 | 56.27 | 47.00 | 50.00 | 2.686M |
Apr 10, 2024 | 39.00 | 49.00 | 38.08 | 44.62 | 3.343M |
Apr 09, 2024 | 38.60 | 40.54 | 38.43 | 40.03 | 703432.0 |
Apr 08, 2024 | 35.46 | 39.05 | 34.92 | 38.63 | 300488.0 |
Apr 05, 2024 | 35.16 | 35.68 | 34.63 | 35.12 | 278739.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.85
Minimum
Nov 09 2023
64.78
Maximum
May 03 2024
17.65
Average
14.19
Median
Price Benchmarks
Viking Therapeutics Inc | 74.80 |
Equillium Inc | 1.735 |
Minerva Neurosciences Inc | 2.47 |
Arvinas Inc | 31.61 |
Calidi Biotherapeutics Inc | 0.2403 |
Price Related Metrics
PS Ratio | 272.02 |
Price to Book Value | 7.496 |
Earnings Yield | -2.66% |
Market Cap | 2.581B |